• FindA University Ltd Featured PhD Programmes
  • University of Tasmania Featured PhD Programmes
  • Staffordshire University Featured PhD Programmes
  • Aberdeen University Featured PhD Programmes
  • University of Pennsylvania Featured PhD Programmes
  • University of Cambridge Featured PhD Programmes
University of York Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of Bristol Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of Reading Featured PhD Programmes

Development of a novel bioassay for UVA-induced skin damage

This project is no longer listed in the FindAPhD
database and may not be available.

Click here to search the FindAPhD database
for PhD studentship opportunities
  • Full or part time
    Dr Allinson
    Prof Mcmillan
  • Application Deadline
    No more applications being accepted
  • Funded PhD Project (UK Students Only)
    Funded PhD Project (UK Students Only)

Project Description

Exposure to environmental ultraviolet radiation (UV) can cause a number of short- and long-term negative effects in human skin, including erythema (burning), skin cancer and ageing. These harmful effects can be mitigated by the application of sunscreens, with the effectiveness of these being expressed in terms of a sun protection factor (SPF) related to the UV dose required for erythema.
Longer wavelength UV (UVA; 315-400 nm) was until recently comparatively neglected in terms of its health impact and it is still the case that many sunscreens do not provide significant protection against this type of radiation. UVA exposure does not result in erythema but is able to cause skin cancer and is also considered to be the major player in UV-induced skin ageing. The standard method for assaying the effectiveness of sunscreens therefore does not adequately evaluate the protection offered against UVA. Moreover, ongoing research in our laboratories and others have shown that the cellular response to UVA is significantly different from the response to shorter wavelength UVB, and that established biomarkers of UV exposure (e.g. p53 activation) may underestimate the damage caused by UVA.
The aim of the project will be to evaluate biomarkers for UVA exposure in a biologically relevant in vitro test system to be developed as part of the project. Work carried out by Dr Allinson and Prof McMillan in collaboration with Boots has identified several potential short- and long-term biomarkers for UVA damage. These will be evaluated for robustness using different skin cell culture models.

Funding Notes

The project is supported by a 4 year BBSRC PhD studentship, covering tuition fees plus living costs allowance of £13,590

NB:- Applicants should have at least a 2:1 Honours degree, or equivalent with a biomedical or related focus and fulfil BBSRC eligibility criteria

Please apply by sending a CV and covering letter to Dr Allinson by either email, using the link below, or post (Dr Sarah Allinson, Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster, LA1 4YQ)

Share this page:

Cookie Policy    X